Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-436-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to the O.E.C.D. test guideline 402 with GLP compliance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Reaction products of 2-methylimidazole and 2,2'-[(1- methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
- EC Number:
- 701-436-0
- Molecular formula:
- (C15H16O2.C4H6N2.C3H5ClO)x
- IUPAC Name:
- Reaction products of 2-methylimidazole and 2,2'-[(1- methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- As per IUCLID5 Sections 1.1. 1.2. 1.4. and 4.1.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The rats were acquired from Charles River (UK) Limited, Margate, Kent and were weighing approximately 200gm and 9-10 weeks of age. The animals were housed in an animal room with temperature maintained within the range 19-25°C and recorded relative humidity within the range 30-62 % The room was illuminated by fluorescent light to give an artificial cycle of 12 hours light/12 hours dark per day.
Animals were housed singly, in grid-bottomed cages suspended over cardboard lined excreta trays. A pelleted diet (SQC Rat and Mouse Maintenance Diet No. I Expanded, produced by Special Diets Services, Witham, Essex) and mains drinking water in polypropylene bottles were freely available. All animals were acclimatised for 5 days before dosing.
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- On the day before dosing, an area on the back of each animal, comprising approximately 10% of the total body surface area, was clipped free of hair. On the day of dosing, designated day one, all animals were weighed. A dose of test substance, determined from the individual bodyweight, was spread evenly over a strip of 4 ply thick gauze and was moistened with water to ensure good skin contact. The gauze was then placed on to the prepared skin site so that the test substance was in contact with the skin. The gauze was then covered with a strip of aluminium foil. The trunk of each animal was encircled with a length of 5cm wide non-irritant surgical tape to secure the dressing and foil and the animals were returned to their cages.
- Duration of exposure:
- 24 hr.
- Doses:
- 2000 mf/Kg of body weight.
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Following the 24 hr occlusive exposure, the dressings were removed and the treated site cleansed with warm water to remove any residual test substance. The animals were examined shortly after dosing and approximately 30 minutes, one, 2 and 4 hours after dosing. Observations including examination of the application site were conducted daily thereafter for a further 14 days. The animals placed on study were weighed on Day one and again on days 8 and 15.
At study termination all animals were weighed and then sacrificed by carbon dioxide asphyxiation at the end of the 15 day observation period. All animals were subject to gross necropsy which included the opening of the thoracic and visceral cavities, opening and examination of the stomach and representative sections of the gastro-intestinal tract and examination of the major organs. Abnormal tissues and organs were preserved in neutral buffered formaldehyde but were not processed further. - Statistics:
- None conducted.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: No adverse clinical signs.
- Gross pathology:
- No adverse findings.
- Other findings:
- No evidence of dermal irritation.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The acute dermal LD50 value for the test substance to the rat was > 2000 mg/Kg of body weight. Therefore, the test substance is not acutelly toxic by the dermal route of exposure.
- Executive summary:
The acute dermal toxicty of the test substance, Bisphenol A, epichlorohydrin polymer, 2-methylimidazole condensate, was accessed by an O.E.C.D. test guideline 402 study in the rat. The acute dermal LD50 value for the test substance to the rat was > 2000 mg/Kg of body weight. Therefore, the test substance is not acutelly toxic by the dermal route of exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.